Biocept Stock Technical Analysis
| BIOCQ Stock | 0.0001 0.00 0.00% |
As of the 3rd of March, Biocept shows the Mean Deviation of 58.9, standard deviation of 234.66, and Risk Adjusted Performance of 0.1003. Biocept technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Biocept Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biocept, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioceptBiocept's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Can Biotechnology industry sustain growth momentum? Does Biocept have expansion opportunities? Factors like these will boost the valuation of Biocept. Projected growth potential of Biocept fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Biocept demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (48.17) | Revenue Per Share | Quarterly Revenue Growth (0.90) | Return On Assets | Return On Equity |
Understanding Biocept requires distinguishing between market price and book value, where the latter reflects Biocept's accounting equity. The concept of intrinsic value - what Biocept's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Biocept's price substantially above or below its fundamental value.
It's important to distinguish between Biocept's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biocept should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biocept's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Biocept 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biocept's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biocept.
| 12/03/2025 |
| 03/03/2026 |
If you would invest 0.00 in Biocept on December 3, 2025 and sell it all today you would earn a total of 0.00 from holding Biocept or generate 0.0% return on investment in Biocept over 90 days. Biocept is entity of United States. It is traded as Stock on NASDAQ exchange. More
Biocept Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biocept's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biocept upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1196 | |||
| Maximum Drawdown | 1995.0 |
Biocept Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biocept's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biocept's standard deviation. In reality, there are many statistical measures that can use Biocept historical prices to predict the future Biocept's volatility.| Risk Adjusted Performance | 0.1003 | |||
| Jensen Alpha | 29.74 | |||
| Total Risk Alpha | 16.63 | |||
| Treynor Ratio | (0.63) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biocept's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biocept March 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1003 | |||
| Market Risk Adjusted Performance | (0.62) | |||
| Mean Deviation | 58.9 | |||
| Coefficient Of Variation | 834.93 | |||
| Standard Deviation | 234.66 | |||
| Variance | 55067.51 | |||
| Information Ratio | 0.1196 | |||
| Jensen Alpha | 29.74 | |||
| Total Risk Alpha | 16.63 | |||
| Treynor Ratio | (0.63) | |||
| Maximum Drawdown | 1995.0 | |||
| Skewness | 8.05 | |||
| Kurtosis | 65.17 |
Biocept Backtested Returns
Biocept secures Sharpe Ratio (or Efficiency) of -0.0387, which signifies that the company had a -0.0387 % return per unit of risk over the last 3 months. Biocept exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biocept's Standard Deviation of 234.66, mean deviation of 58.9, and Risk Adjusted Performance of 0.1003 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -44.62, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Biocept are expected to decrease by larger amounts. On the other hand, during market turmoil, Biocept is expected to outperform it. At this point, Biocept has a negative expected return of -0.73%. Please make sure to confirm Biocept's variance and kurtosis , to decide if Biocept performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Biocept has no correlation between past and present. Overlapping area represents the amount of predictability between Biocept time series from 3rd of December 2025 to 17th of January 2026 and 17th of January 2026 to 3rd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biocept price movement. The serial correlation of 0.0 indicates that just 0.0% of current Biocept price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Biocept technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Biocept Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Biocept across different markets.
About Biocept Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biocept on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biocept based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Biocept price pattern first instead of the macroeconomic environment surrounding Biocept. By analyzing Biocept's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biocept's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biocept specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2025 | 2026 (projected) | Payables Turnover | 5.21 | 18.67 | 16.81 | 17.65 | Days Of Inventory On Hand | 25.62 | 9.72 | 11.17 | 10.61 |
Biocept March 3, 2026 Technical Indicators
Most technical analysis of Biocept help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biocept from various momentum indicators to cycle indicators. When you analyze Biocept charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1003 | |||
| Market Risk Adjusted Performance | (0.62) | |||
| Mean Deviation | 58.9 | |||
| Coefficient Of Variation | 834.93 | |||
| Standard Deviation | 234.66 | |||
| Variance | 55067.51 | |||
| Information Ratio | 0.1196 | |||
| Jensen Alpha | 29.74 | |||
| Total Risk Alpha | 16.63 | |||
| Treynor Ratio | (0.63) | |||
| Maximum Drawdown | 1995.0 | |||
| Skewness | 8.05 | |||
| Kurtosis | 65.17 |
Biocept March 3, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Biocept stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 0.00 | ||
| Day Typical Price | 0.00 | ||
| Price Action Indicator | 0.00 |
Additional Tools for Biocept Stock Analysis
When running Biocept's price analysis, check to measure Biocept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocept is operating at the current time. Most of Biocept's value examination focuses on studying past and present price action to predict the probability of Biocept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocept's price. Additionally, you may evaluate how the addition of Biocept to your portfolios can decrease your overall portfolio volatility.